Skip to main content
Top

19-04-2024 | Hyperparathyroidism | Clinical Investigation

Radiofrequency Ablation of Parathyroid Adenoma: Results of a Retrospective Analysis of 60 Patients

Authors: Haleh Chehrehgosha, Hossein Chegini, Iraj Heydari, Hojat Ebrahiminik, Rambod Salouti, Jafar Golzarian

Published in: CardioVascular and Interventional Radiology

Login to get access

Abstract

Purpose

To present the effectiveness and safety of radiofrequency ablation (RFA) in parathyroid adenoma (PTA).

Materials and Methods

In this retrospective study, 60 patients with a single PTA were evaluated for changes in biochemical and ultrasonographic features up to 6 months after RFA of the lesion. Adenomas were ablated with an alternative technique so called “Nik jet dissection” which incorporates full hydrodissection and polar artery coagulation. Complications as well as the variations in biochemical data and nodule volumes were analyzed between baseline measurements and at each follow-up interval data (first day, 1, 3, and 6 months after ablation) were analyzed.

Results

A significant reduction in serum intact parathyroid hormone and calcium levels was observed 6 months after ablation, with a mean difference of − 83.4 ± 104.1 pg/mL, p < 0.001, and − 0.29 ± 0.22 mmol/L, p < 0.001, respectively. Serum phosphorus levels increased significantly with a mean difference of 0.09 ± 0.19 mmol/L, p = 0.040 at the end of the follow up. We observed a significant volume reduction rate of parathyroid adenomas with 89 ± 20.8 percent, p < 0.001. Also, 51% of adenomas disappeared at the end of the follow up. In this study, two cases of hematoma and one case of transient hoarseness (grade 1 of the CIRSE classification) were encountered.

Conclusion

Our study showed that RFA with the alternative technique, called “Nik jet dissection” is a safe and effective modality in management of PTA. Therefore, we suggest expanding the indications for RFA in PTA management, especially when surgery is not feasible.

Level of Evidence

Level 3, Local non-random sample.

Graphical Abstract

Literature
1.
go back to reference Chai HH, Zhao Y, Zeng Z, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for primary hyperparathyroidism: a prospective study. Korean J Radiol. 2022;23:555.CrossRefPubMedPubMedCentral Chai HH, Zhao Y, Zeng Z, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for primary hyperparathyroidism: a prospective study. Korean J Radiol. 2022;23:555.CrossRefPubMedPubMedCentral
2.
go back to reference Kim BS, Eom TI, Kang KH, Park SJ. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrason. 2014;41:239–43.CrossRef Kim BS, Eom TI, Kang KH, Park SJ. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrason. 2014;41:239–43.CrossRef
3.
go back to reference Wei Y, Peng CZ, Wang SR, et al. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study. J Clin Endocrinol Metab. 2021;106:2707–17.CrossRefPubMedPubMedCentral Wei Y, Peng CZ, Wang SR, et al. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study. J Clin Endocrinol Metab. 2021;106:2707–17.CrossRefPubMedPubMedCentral
4.
go back to reference Ebrahiminik H, Chegeni H, Mosadegh Khah A, et al. Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: a report of 27 patients. J Clin Ultrasound. 2022;50:540–6.CrossRefPubMed Ebrahiminik H, Chegeni H, Mosadegh Khah A, et al. Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: a report of 27 patients. J Clin Ultrasound. 2022;50:540–6.CrossRefPubMed
5.
go back to reference Pareja FG, Naranjo PP, Olmedilla MR, Peña ÁC. Radiofrequency ablation for thyroid and parathyroid disease. Radiología (English Edition). 2022;64:383–92.CrossRef Pareja FG, Naranjo PP, Olmedilla MR, Peña ÁC. Radiofrequency ablation for thyroid and parathyroid disease. Radiología (English Edition). 2022;64:383–92.CrossRef
6.
go back to reference Khandelwal AH, Batra S, Jajodia S, et al. Radiofrequency ablation of parathyroid adenomas: safety and efficacy in a study of 10 patients. Indian J Endocrinol Metab. 2020;24:543.CrossRefPubMed Khandelwal AH, Batra S, Jajodia S, et al. Radiofrequency ablation of parathyroid adenomas: safety and efficacy in a study of 10 patients. Indian J Endocrinol Metab. 2020;24:543.CrossRefPubMed
7.
go back to reference Hansler J, Harsch IA, Strobel D, Hahn EG, Becker D. Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous radio-frequency-tissue-ablation (RFTA). Article German Ultraschall Med. 2002;23:202–6.PubMed Hansler J, Harsch IA, Strobel D, Hahn EG, Becker D. Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous radio-frequency-tissue-ablation (RFTA). Article German Ultraschall Med. 2002;23:202–6.PubMed
8.
go back to reference Chen CC, Chen HL, Chiang PL, et al. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study. Int J Hyperthermia. 2022;39:907–17.CrossRefPubMed Chen CC, Chen HL, Chiang PL, et al. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study. Int J Hyperthermia. 2022;39:907–17.CrossRefPubMed
9.
go back to reference Axelsson KF, Wallander M, Johansson H, et al. Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism. JAMA netw open. 2022;5:e2215396.CrossRefPubMedPubMedCentral Axelsson KF, Wallander M, Johansson H, et al. Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism. JAMA netw open. 2022;5:e2215396.CrossRefPubMedPubMedCentral
10.
go back to reference Ren M, Zheng D, Wu J, et al. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Sci Rep. 2022;12:10289.CrossRefPubMedPubMedCentral Ren M, Zheng D, Wu J, et al. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Sci Rep. 2022;12:10289.CrossRefPubMedPubMedCentral
11.
go back to reference Zhang DL, Chen S, Gao MZ, et al. Ultrasound-guided radiofrequency ablation: a new attempt to the treatment of refractory hyperparathyroidism secondary to chronic kidney disease. Kidney Int Rep. 2022;7:282–8.CrossRefPubMed Zhang DL, Chen S, Gao MZ, et al. Ultrasound-guided radiofrequency ablation: a new attempt to the treatment of refractory hyperparathyroidism secondary to chronic kidney disease. Kidney Int Rep. 2022;7:282–8.CrossRefPubMed
12.
go back to reference Hussain I, Ahmad S, Aljammal J. Radiofrequency ablation of parathyroid adenoma: a novel treatment option for primary hyperparathyroidism. AACE Clin Case Rep. 2021;7:195–9.CrossRefPubMedPubMedCentral Hussain I, Ahmad S, Aljammal J. Radiofrequency ablation of parathyroid adenoma: a novel treatment option for primary hyperparathyroidism. AACE Clin Case Rep. 2021;7:195–9.CrossRefPubMedPubMedCentral
13.
go back to reference Wei Y, Zhao ZL, Cao XJ, et al. Microwave ablation versus parathyroidectomy for the treatment of primary hyperparathyroidism: a cohort study. Eur Radiol. 2022;32:5821–30.CrossRefPubMedPubMedCentral Wei Y, Zhao ZL, Cao XJ, et al. Microwave ablation versus parathyroidectomy for the treatment of primary hyperparathyroidism: a cohort study. Eur Radiol. 2022;32:5821–30.CrossRefPubMedPubMedCentral
15.
go back to reference Peng CZ, Chai HH, Zhang ZX, et al. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation. Int J Hyperthermia. 2022;39:490–6.CrossRefPubMed Peng CZ, Chai HH, Zhang ZX, et al. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation. Int J Hyperthermia. 2022;39:490–6.CrossRefPubMed
16.
go back to reference Ha EJ, Baek JH, Baek SM. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol. 2020;21:1388.CrossRef Ha EJ, Baek JH, Baek SM. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol. 2020;21:1388.CrossRef
17.
go back to reference Caldwell M, Laux J, Clark M, Kim L, Rubin J. Persistently elevated PTH after parathyroidectomy at one year: experience in a tertiary referral center. J Clin Endocrinol Metabol. 2019;104:4473–80.CrossRef Caldwell M, Laux J, Clark M, Kim L, Rubin J. Persistently elevated PTH after parathyroidectomy at one year: experience in a tertiary referral center. J Clin Endocrinol Metabol. 2019;104:4473–80.CrossRef
18.
go back to reference Beltsevich DG, Voskoboynikov VV, Klycheva CM, Roslyakova AA, Ladygina DO. Role of parathyroid hormone measurement in fine-needle aspiration biopsy washout in diagnosis and treatment of primary hyperparathyroidism. Osteoporos Bone Dis. 2018;20:108–13.CrossRef Beltsevich DG, Voskoboynikov VV, Klycheva CM, Roslyakova AA, Ladygina DO. Role of parathyroid hormone measurement in fine-needle aspiration biopsy washout in diagnosis and treatment of primary hyperparathyroidism. Osteoporos Bone Dis. 2018;20:108–13.CrossRef
19.
go back to reference Wilhelm SM, Wang TS, Ruan DT, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA surg. 2016;151:959–68.CrossRefPubMed Wilhelm SM, Wang TS, Ruan DT, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA surg. 2016;151:959–68.CrossRefPubMed
Metadata
Title
Radiofrequency Ablation of Parathyroid Adenoma: Results of a Retrospective Analysis of 60 Patients
Authors
Haleh Chehrehgosha
Hossein Chegini
Iraj Heydari
Hojat Ebrahiminik
Rambod Salouti
Jafar Golzarian
Publication date
19-04-2024
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-024-03725-w